436 research outputs found

    On central LL-values and the growth of the 33-part of the Tate-Shafarevich group

    Full text link
    Given any cube-free integer λ>0\lambda>0, we study the 33-adic valuation of the algebraic part of the central LL-value of the elliptic curve X3+Y3=λZ3.X^3+Y^3=\lambda Z^3. We give a lower bound in terms of the number of distinct prime factors of λ\lambda, which, in the case 33 divides λ\lambda, also depends on the power of 33 in λ\lambda. This extends an earlier result of the author in which it was assumed that 33 is coprime to λ\lambda. We also study the 33-part of the Tate-Shafarevich group for these curves and show that the lower bound is as expected from the conjecture of Birch and Swinnerton-Dyer, taking into account also the growth of the Tate-Shafarevich group.Comment: 15 pages. A 3-descent argument has been added to Section

    Tamagawa number divisibility of central LL-values of twists of the Fermat elliptic curve

    Get PDF
    Given any integer N>1N>1 prime to 33, we denote by CNC_N the elliptic curve x3+y3=Nx^3+y^3=N. We first study the 33-adic valuation of the algebraic part of the value of the Hasse-Weil LL-function L(CN,s)L(C_N,s) of CNC_N over Q\mathbb{Q} at s=1s=1, and we exhibit a relation between the 33-part of its Tate-Shafarevich group and the number of distinct prime divisors of NN which are inert in the imaginary quadratic field K=Q(3)K=\mathbb{Q}(\sqrt{-3}). In the case where L(CN,1)0L(C_N,1)\neq 0 and NN is a product of split primes in KK, we show that the order of the Tate-Shafarevich group as predicted by the conjecture of Birch and Swinnerton-Dyer is a perfect square.Comment: 21 pages. To appear in the Journal de Th\'{e}orie des Nombres de Bordeaux (Iwasawa 2019 special issue

    Analysis of the Pathogenesis of Experimental Autoimmune Optic Neuritis

    Get PDF
    Optic neuritis associated with multiple sclerosis has a strong association with organ-specific autoimmune disease. The goal of our research is to establish an optimal organ-specific animal model to elucidate the pathogenetic mechanisms of the disease and to develop therapeutic strategies using the model. This paper is divided into five sections: (1) clinical picture of optic neuritis associated with multiple sclerosis, (2) elucidation of pathogenesis using animal models with inflammation in optic nerve and spinal cord, (3) clinical relevance of concurrent encephalomyelitis in optic neuritis model, (4) retinal damage in a concurrent multiple sclerosis and optic neuritis model, and (5) development of novel therapies using mouse optic neuritis model. Advanced therapies using biologicals have succeeded to control intractable optic neuritis in animal models. This may ultimately lead to prevention of vision loss within a short period from acute onset of optic neuritis in human. By conducting research flexibly, ready to switch from the bench to the bedside and from the bedside to the bench as the opportunity arises, this strategy may help to guide the research of optic neuritis in the right direction

    Studies of the Genus Bupleurum (Umbelliferae) from Nepal: (1) A Histological Study of Leaves and the Botanical Origin of Tibetan Crude Drug Tunak Chunga

    Get PDF
    ネパール産のセリ科ミシマサイコ属(Bupleurum)8分類群の葉を比較組織学的に検討し,本属の組織分類学的な要素を明らかにするとともに,ネパールの高山帯で薬用として利用されているチベット薬物 TUNAK CHUNGA の基源解明を試みた.その結果,組織学的には茎の中央部付近の葉において,横切面における主脈部や葉縁部の形,厚角組織の発達状態,油道の存在数,乳状突起の有無や上面の気孔の分布数などの形質で全種を分類することが可能であった(Table 1).また TUNAK CHUNGA の基源は,ネパール高山帯の本属植物では資源的にもっとも豊富なB. falcatum subsp. falcatum var. gracillimum の全草であることが明らかになった.本種はチベット薬物の原植物としての初めての記録である
    corecore